Alcami Capacity Update January 2025: Fill/Finish

Alcami is a globally recognized contract development and manufacturing organization (CDMO) committed to transforming patient outcomes by partnering with clients to bring innovative, life-changing medicines to market. We offer reliable, end-to-end solutions that unlock the potential of transformative therapies, spanning discovery to commercialization, supported by trusted partnerships, industry-leading expertise, and a proven regulatory compliance record. Our broad capabilities encompass the development and manufacturing of small and large molecules, lyophilized products, complex formulations, and DEA-scheduled drug products. In addition to state-of-the-art sterile fill-finish (parenteral) services, Alcami specializes in oral solid dose development, solid-state characterization, clinical manufacturing, batch scaling, and commercial production.

Alcami’s sterile drug product fill-finish services include formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing. Equipped with advanced isolator and Restricted Access Barrier Systems (RABs) technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes. Additional capabilities include terminal sterilization, single-use systems, Annex 1 compliance, temperature- and oxygen-sensitive compounding, and Schedule I-V controlled drug manufacturing. By combining cutting-edge technologies with an unwavering commitment to quality, Alcami delivers innovative solutions that empower clients to bring transformative therapies to patients around the world.